Company Overview of Plandaí Biotechnology, Inc.
Plandaí Biotechnology, Inc. focuses on the production of proprietary botanical extracts for the nutriceutical and pharmaceutical industries. It is developing two extracts, including Phytofare Catechin Complex, which is derived from green tea harvested in the Senteeko Tea Estate in Mpumalanga, South Africa; and Phytofare Limonoid Glycoside Complex extracted from lemons that are sourced from plantations in South Africa. The company also produces and sells timber and agricultural products from its farm and tea estate holdings in South Africa. In addition, it intends to use its plantation leases to focus on the farming of whole fruits, vegetables, and live plant material. The company is based in...
1451 North 200 East
Logan, UT 98102
Key Executives for Plandaí Biotechnology, Inc.
Co-Founder, Chairman, Chief Executive Officer, President, Chief Financial Officer, Principal Accounting Officer and Secretary
Total Annual Compensation: $117.5K
Vice President of Sales and Director
Total Annual Compensation: $95.0K
Vice President of Marketing and Director
Total Annual Compensation: $9.0K
Compensation as of Fiscal Year 2014.
Plandaí Biotechnology, Inc. Key Developments
Ultimate Sports Nutrition Develops New Products Using Phytofare
Aug 26 15
Plandai Biotechnology, Inc. announced that Ultimate Sports Nutrition (USN) is investigating and developing a new line of products for the Australian and New Zealand markets that incorporates Plandai's green tea catechin-based Phytofare(R) ingredient. Under the terms of a previously announced agreement, USN is committed to using Phytofare(R) catechin complex exclusively in all products manufactured or sold in Europe and South Africa that incorporate green tea. In an effort to further develop and expand on the existing agreement, the Company and USN agreed to allow USN to explore the use of Phytofare(R) with other USN contract manufacturers, beginning in Australia and New Zealand, in an attempt to determine whether further expansion of the relationship between the Company and USN was desirable.
Plandaí Biotechnology, Inc. Announces Expansion of Agreement with USN to Now Include the European Union
Aug 10 15
Plandai Biotechnology, Inc. announced an amendment to its previously announced agreement with USN Worldwide. By virtue of the amended agreement with USN, the company will now expand its exclusive PhytofareA(R) sales to USN and its contract manufacturers to the European Union. Under the terms of the revised three-year agreement, USN has agreed to use PhytofareA(R) as the exclusive green tea ingredient in their manufactured supplements in exchange for guaranteed pricing and availability concessions from Plandai.
Plandai Biotechnology to Deliver Green Tea Extract to USN
Jul 16 15
Plandaí Biotechnology reported that Azochem Laboratories, a contract manufacturer for USN in South Africa, placed the second USN related purchase order for the company's Phytofare Catechin Complex The exclusive agreement between Plandai and USN will allow USN to control the input costs around production, while enhancing product efficacy by replacing the generic green tea extracts it now uses in its lineup of products, with the clinically proven highly bio available Phytofare Catechin Complex.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries